- Home
- MRNO vs SLP Comparison
MRNO vs SLP Comparison
Compare MRNO & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNO
- SLP
- Stock Information
- Founded
- MRNO 2021
- SLP 1996
- Country
- MRNO United Kingdom
- SLP United States
- Employees
- MRNO N/A
- SLP N/A
- Industry
- MRNO
- SLP EDP Services
- Sector
- MRNO
- SLP Technology
- Exchange
- MRNO NYSE
- SLP Nasdaq
- Market Cap
- MRNO 794.8M
- SLP 708.1M
- IPO Year
- MRNO N/A
- SLP 1997
- Fundamental
- Price
- MRNO $10.74
- SLP $30.02
- Analyst Decision
- MRNO
- SLP Buy
- Analyst Count
- MRNO 0
- SLP 8
- Target Price
- MRNO N/A
- SLP $47.83
- AVG Volume (30 Days)
- MRNO 3.5K
- SLP 448.0K
- Earning Date
- MRNO 05-25-2025
- SLP 07-01-2025
- Dividend Yield
- MRNO N/A
- SLP 0.20%
- EPS Growth
- MRNO N/A
- SLP N/A
- EPS
- MRNO N/A
- SLP 0.36
- Revenue
- MRNO $35,030,945.00
- SLP $78,564,000.00
- Revenue This Year
- MRNO N/A
- SLP $30.38
- Revenue Next Year
- MRNO N/A
- SLP $11.97
- P/E Ratio
- MRNO N/A
- SLP $83.86
- Revenue Growth
- MRNO 154.65
- SLP 21.49
- 52 Week Low
- MRNO $5.70
- SLP $23.01
- 52 Week High
- MRNO $13.25
- SLP $51.22
- Technical
- Relative Strength Index (RSI)
- MRNO 57.28
- SLP 45.26
- Support Level
- MRNO $10.00
- SLP $27.85
- Resistance Level
- MRNO $12.24
- SLP $36.45
- Average True Range (ATR)
- MRNO 0.60
- SLP 1.59
- MACD
- MRNO 0.14
- SLP -0.75
- Stochastic Oscillator
- MRNO 52.98
- SLP 25.23
About MRNO MURANO GLOBAL INVESTMENTS LIMITED
Murano Global Investments PLC is a real estate company that owns, develops, and invests in hotel, resort, and commercial properties throughout Mexico. Its portfolio includes the Andaz and Mondrian Hotels in Mexico City and Vivid Hotel Grand Island. The revenues are derived from the products and services provided to our customers such as Room rentals, Food and beverage, Private events, Spa services, and Other services.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.